Patents by Inventor Yunzhe SUN

Yunzhe SUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11786522
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: October 17, 2023
    Assignee: Nanjing Noratech Pharmaceuticals Co., LTD
    Inventors: Yunzhe Sun, Qi Peng, Cheng-Gang Lin, Li Gui, Zhihui Liu, Fei Liu
  • Publication number: 20230255960
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Applicant: NANJING NORATECH PHARMACEUTICALS CO., LTD.
    Inventors: Yunzhe SUN, Qi PENG, Cheng-Gang LIN, Li GUI, Zhihui LIU, Fei LIU
  • Publication number: 20190070171
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Application
    Filed: March 16, 2016
    Publication date: March 7, 2019
    Applicant: NORATECH PHARMACEUTICALS, INC.
    Inventors: Yunzhe SUN, Qi PENG, Cheng-Gang LIN, Li GUI, Zhihui LIU, Fei LIU